SEC Form 4 research
| Issuer | Valeant Pharmaceuticals International, Inc. |
|---|---|
| Tickers | VRX, BHC, BVF, BVL |
| Reporting owners | 93 |
| Officers and directors | 43 |
| Last public filing | 2026-10-02 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-02 | 2026-09-30 | Paulson John | A | 10,720 | $5.83 | Not reported |
| 2026-10-02 | 2026-09-30 | LEUNG SANDRA | A | 5,789 | $5.83 | Not reported |
| 2026-10-02 | 2026-09-30 | WECHSLER AMY B | A | 1,179 | $5.83 | Not reported |
| 2026-08-20 | 2026-08-19 | Lenar Aimee J. | S | 36,827 | $7.03 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.